TradingView
RocketTickers
Feb 14, 2019 8:20 PM
RARE Announce Positive 64-Week Results for Crysvita® (burosumab)
Long
NASDAQ:RARE
1D
Ultragenyx Pharmaceutical Inc.
NASDAQ
Description
⋅
Feb 14, 2019 8:20 PM
2019-02-14 08:30:00
Ultragenyx and Kyowa Kirin Announce Positive 64-Week Results for Crysvita® (burosumab) from Phase 3 Study in Children with X-linked Hypophosphatemia (XLH)
Beyond Technical Analysis
More